GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
Two Clinical-Stage Biopharmas Enter Agreement to Develop Drug for Hematologic Malignancies
2020-10-14
ITRI and Gemseki Agreed on the Collaboration of Licensing Activities
2020-10-13
ITALY Pavilion Offers Immense Value at BIO ASIA-TAIWAN 2020 – ONLINE
2020-10-13Partner
HoldingTOP Delivers a Mobilized Long-Term Care Service, a First in Taiwan
2020-10-13Partner
Innovent Biologics Bags Chinese Approval for Fourth Monoclonal Antibody
2020-10-12
Takeda Collaborates with Arrowhead to Overcome Inherited Disorder via RNAi Therapy
2020-10-10
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
China-Based Immunotherapy Company Receives FDA’s Orphan Drug Designation for Advanced Gastric Cancer Treatment
2020-10-07
Tokyo-Based Genomics Company Launches World’s First Cell-Free DNA Amplification Process
2020-10-04
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
China Approves Avastin’s New Indication
2020-09-25
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
Eisai Enters Vietnam With a Subsidiary
2020-09-18
3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
2020-09-16
Korean Ginseng Gets Approved for a Functional Ingredient for Bone Health
2020-09-13
1 22 23 24 25 26 35
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top